[go: up one dir, main page]

Antonenas et al., 2006 - Google Patents

Optimum temperature for maintaining the viability of CD34+ cells during storage and transport of fresh haematopoietic progenitor cells

Antonenas et al., 2006

View PDF
Document ID
6290007067931850245
Author
Antonenas V
Garvin F
Sartor M
Bradstock K
Gottlieb D
Publication year
Publication venue
Biology of Blood and Marrow Transplantation

External Links

Snippet

HSCs are rare cells resident in the bone marrow. HSCs must be capable of robust proliferation and self-renewal. The regulation of HSC proliferation occurs at least partly through interactions with the microenvironment, or niche. We found that in contrast to other …
Continue reading at www.tctjournal.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells

Similar Documents

Publication Publication Date Title
Smith et al. Standardizing umbilical cord mesenchymal stromal cells for translation to clinical use: selection of GMP‐compliant medium and a simplified isolation method
CA3103505C (en) Methods for collecting and using placenta cord blood stem cells
JP2013514072A (en) Methods for isolating mononuclear cells containing a subpopulation of mesenchymal progenitor cells and vascular cells containing a subpopulation of endothelial progenitor cells from umbilical cord tissue
BRPI0709349A2 (en) methods for cell expansion and uses of cells and conditioned media produced through them for therapy
TW200902718A (en) Procurement, isolation, and cryopreservation of endometrial/menstrual cells
Sultana et al. Current status of canine umbilical cord blood‐derived mesenchymal stem cells in veterinary medicine
US20090016997A1 (en) Autologous/allogeneic human DNA grafting, anti-and reverse aging stem cell, and bone marrow compositions/methods
Roura et al. Impact of Umbilical Cord Blood‐Derived Mesenchymal Stem Cells on Cardiovascular Research
Shangaris et al. Long-term hematopoietic engraftment of congenic amniotic fluid stem cells after in utero intraperitoneal transplantation to immune competent mice
US20170224736A1 (en) Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof
US11760976B2 (en) Stem cells and decellularization of tissue matrix from cord tissue
Singh et al. Stem cells: The holy grail of regenerative medicine
Chan et al. The multiple facets of hematopoietic stem cells
Yankelevich et al. The role of cytotoxic T cell antigen-2 (CTLA2) in mouse hematopoietic stem cell (HSC) transplant engraftment and reconstitution examined by lentiviral vector transduction
Antonenas et al. Optimum temperature for maintaining the viability of CD34+ cells during storage and transport of fresh haematopoietic progenitor cells
Beam et al. Expansion of umbilical cord blood derived oligodendrocytes
Verma et al. Cord blood banking: An Indian perspective
US9670457B2 (en) Stem cells and matrix from cord tissue
US20190357524A1 (en) Preservative solution for human stem cells, human stem cell suspension, and method for preserving human stem cells
Chow et al. Advances in umbilical cord blood therapy: Hematopoietic stem cell transplantation and beyond
Atala et al. Perinatal stem cells
US20240026299A1 (en) Stem cell and tissue cultures and their products
Caprio et al. The Effect of Replacing Fetal Bovine Serum with Platelet Releasate on the Characterization of MSCs
Fergany Faculty of Biotechnology Research Project RS400 (Pre-Cryopreservation Umbilical Cord Blood quality: The significance of Gestational age and
Majhail et al. Diffuse alveolar hemorrhage (DAH) and infection associated alveolar hemorrhage (IAH) following hematopoietic stem-cell transplantation: related and high risk clinical syndromes with poor response to high-dose corticosteroids